Lorazepam in Anxiety: A Controlled Study
1974; SAGE Publishing; Volume: 2; Issue: 1 Linguagem: Inglês
10.1177/030006057400200104
ISSN1473-2300
AutoresK Rickeis, I Csanalosi, J A Pereira-Ogan, L Parish, P J Bell,
Tópico(s)Memory and Neural Mechanisms
ResumoLorazepam ( 3 mg/day) was compared to placebo in a double-blind controlled study conducted with anxious neurotic out-patients. Sixty-eight patients were treated for at least two weeks. Significant main treatment effects were found with lorazepam producing more improvement than placebo in physician but not patient-completed measures. Lorazepam seemed to be most effective in the initially sicker patients. Its main side-effect was sedation.
Referência(s)